Researchers at the University of California, Irvine, have found that some antibody-drug conjugates, an emerging class of targeted cancer therapies, were associated with serious infection-related complications, including hospitalization and intensive care admissions. The study analyzed treatment data from 3,511 patients…
Oncology
Norfolk, Va.-based Sentara Health will launch the first vertically integrated theranostics program in Virginia. The program will be established in partnership with biotechnology firm BAMF Health, according to a May 28 news release from Sentara Health. Theranostics offers treatment for…
A personalized mRNA cancer vaccine combined with immunotherapy cut melanoma recurrence risk by 49%, according to a study published June 1 in the Journal of Clinical Oncology and simultaneously presented at the American Society of Clinical Oncology annual meeting in…
Precision oncology has long been discussed as the future of cancer care, initially focused on advanced disease management and treatment selection. Today, Molecular Residual Disease (MRD) and Multi-Cancer Early Detection (MCED) are expanding that vision beyond late-stage care and into…
Salt Lake City-based Huntsman Cancer Institute at the University of Utah has launched a care affiliation with Portneuf Cancer Center, part of Pocatello, Idaho-based Portneuf Medical Center. Through the partnership, Portneuf Cancer Center will integrate Huntsman Cancer Institute’s clinical expertise…
Advertisement
Researchers at Philadelphia-based Penn Medicine have found women who used GLP-1 medications were about 30% less likely to develop breast cancer than women who did not use the drugs. Here are five notes:
An implanted radiation device has improved tumor control and overall survival compared with standard radiation therapy in patients with newly diagnosed operable brain metastases, according to phase 3 clinical trial data presented May 30 at the American Society of Clinical…
Health systems across the U.S. have experienced an uptake in patient demand for the pancreatic cancer drug daraxonrasib in the weeks since the FDA granted expanded access to the drug through a May 1 “safe to proceed” letter. Demand heightened…
Among 11 cancer hospitals exempt from reporting to Medicare’s Inpatient Prospective Payment System, eight cancer hospitals have a five-star rating for nurse communication, but two facilities have five-star ratings for physician communications, according to CMS data published May 13. Eleven…
Coral Gables, Fla.-based Baptist Health South Florida will launch an early-phase cancer clinical trial site in partnership with San Antonio-based START Center for Cancer Research. The site will operate in collaboration with Baptist Health’s Herbert Wertheim Cancer Institute, which was…